{"mainPropery":{"diseaseId":9344,"diseaseName":"Small cell lung cancer","hasGardWebPage":true,"isRare":true,"websiteUrl":"https://rarediseases.info.nih.gov/diseases/9344/small-cell-lung-cancer","synonyms":["Lung Small Cell Carcinoma","Oat cell lung cancer","Small Cell Neuroendocrine Carcinoma of the Lung"],"synonyms-with-source":[{"name":"Lung Small Cell Carcinoma","source":"NCI Thesaurus"},{"name":"Oat cell lung cancer","source":"NCI Thesaurus"},{"name":"Small Cell Neuroendocrine Carcinoma of the Lung","source":"NCI Thesaurus"}],"identifiers":[{"identifierType":"NCI Thesaurus","identifierId":"C4917"}]},"diseaseCategories":[{"diseaseTypeId":1,"diseaseTypeName":"Rare Cancers"}],"organizations":[],"resource descriptions":[{"id":10,"resourceId":13,"resourceName":"MedlinePlus Genetics","descriptionText":"<a href='http://ghr.nlm.nih.gov/condition/lung-cancer' target='_blank'>Genetics Home Reference (GHR)</a> contains information on Small cell lung cancer. This website is maintained by the National Library of Medicine.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"}],"overviewQuestion":{"questionId":0,"dateModified":"0001-01-01T00:00:00"},"basicQuestions":[],"references":[],"relatedDiseases":[{"relatedDiseaseId":9345,"relatedDiseaseName":"Childhood Lung Small Cell Carcinoma","relation":"Child","isRare":true,"hasGardPage":true}],"gardCases":[],"news":[{"newsId":671,"dateCreated":"2020-05-20T13:39:00","publishDate":"2020-05-22T00:00:00","title":"NIH-Supported Research Survey to Examine Impact of COVID-19 on Rare Diseases Community","description":"The NIH-funded Rare Diseases Clinical Research Network (RDCRN) has launched an <a href=\"https://www.rarediseasesnetwork.org/COVIDsurvey \" target=\"_blank\">online research survey</a> to find out how the COVID-19 pandemic is impacting individuals with rare diseases, their families and their caregivers. Your participation can help the rare disease research community shed light on the needs of people with rare diseases during this and other potential health crises, in addition to informing future research efforts. The survey must be completed by December 15, 2020.","url":"https://www.rarediseasesnetwork.org/COVIDsurvey","lastModified":"2020-11-30T14:44:00","isFeatured":false}],"conferences":[],"phenoTypes":[],"medicalProducts":[{"productId":732,"genericName":"Nivolumab","tradeName":"Opdivo","tradeLink":"https://www.opdivo.com/advanced-small-cell-lung-cancer","manufacturer":"","sponsor":"Bristol-Myers Squibb Co","indication":"August 2018, nivolumab (Opdivo) was approved for the treatment of patients with metastatic small cell lung cancer (SCLC) with progression after platinum-based chemotherapy and at least one other line of therapy.","drugInformationLink":"https://druginfo.nlm.nih.gov/drugportal/name/opdivo","medlinePlusLink":"https://medlineplus.gov/druginfo/meds/a614056.html"}],"EncodedName":"Small_cell_lung_cancer"}